Abstract
Preterm infants may pass meconium only after the first 48 hours of life, even in the absence of any gastrointestinal disease. The role of various factors in determining the time of meconium elimination has been recently assessed. Gestational age and start of feeding had been demonstrated to influence first meconium timing. The aim of our study was to evaluate the time of first meconium passage and the time to achieve regular bowel movements (RBM), correlating these two events to different factors such as gestational age (GA), sex, type of delivery [caesarean section (CS) vs spontaneous delivery (SD)], 1 and 5 Apgar score (1AS, 5AS), time and type of feeding, oxygen requirement and any mode of respiratory support.
Keywords: Bowel habit, preterm newborns, first stool passage, meconium, regular bowel movements (RBM)
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Bowel Habit in Preterm New borns: Effect of New Formulas
Volume: 10 Issue: 2
Author(s): Mariella Baldassarre, Margherita Fanelli, Anna Maria Laneve, Roberto Grosso, Felicia Varsalone, Maria Rita Falcone, Fabio Russo, Flora Sportelli and Nicola Laforgia
Affiliation:
Keywords: Bowel habit, preterm newborns, first stool passage, meconium, regular bowel movements (RBM)
Abstract: Preterm infants may pass meconium only after the first 48 hours of life, even in the absence of any gastrointestinal disease. The role of various factors in determining the time of meconium elimination has been recently assessed. Gestational age and start of feeding had been demonstrated to influence first meconium timing. The aim of our study was to evaluate the time of first meconium passage and the time to achieve regular bowel movements (RBM), correlating these two events to different factors such as gestational age (GA), sex, type of delivery [caesarean section (CS) vs spontaneous delivery (SD)], 1 and 5 Apgar score (1AS, 5AS), time and type of feeding, oxygen requirement and any mode of respiratory support.
Export Options
About this article
Cite this article as:
Baldassarre Mariella, Fanelli Margherita, Maria Laneve Anna, Grosso Roberto, Varsalone Felicia, Rita Falcone Maria, Russo Fabio, Sportelli Flora and Laforgia Nicola, Bowel Habit in Preterm New borns: Effect of New Formulas, Endocrine, Metabolic & Immune Disorders - Drug Targets 2010; 10 (2) . https://dx.doi.org/10.2174/187153010791213092
DOI https://dx.doi.org/10.2174/187153010791213092 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?
Current Vascular Pharmacology Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective
Current Pharmacogenomics and Personalized Medicine The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Neuroferritinopathy: Update on Clinical Features and Pathogenesis
Current Drug Targets Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design Assessment of Antihyperglycemic Effect and Acute Toxicity of the Aqueous <i>Scorzonera undulata</i> Extract in Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Personalized Medicine in Psoriasis: Concept and Applications
Current Vascular Pharmacology Potential Usefulness of Clopidogrel Pharmacogenetics in Ce rebral Endovascular Procedures and Carotid Artery Stenting
Current Clinical Pharmacology MIPs as a Versatile Tool for Micro-Solid-Phase Extraction and Probe Sensing
Current Chemical Biology Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Current Topics in Medicinal Chemistry Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19
Current Drug Delivery NMDA Pathology and Treatment of Schizophrenia
Current Pharmaceutical Design Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Progress in the Development of Bestatin Analogues as Aminopeptidases Inhibitors
Current Medicinal Chemistry Adiponectin: Merely a Bystander or the Missing Link to Cardiovascular Disease?
Current Topics in Medicinal Chemistry Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
Recent Patents on Anti-Cancer Drug Discovery New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Beyond Rodent Models of Pain: Non-Human Primate Models for Evaluating Novel Analgesic Therapeutics and Elaborating Pain Mechanisms
CNS & Neurological Disorders - Drug Targets Plumbagin Inhibits Breast Tumor Bone Metastasis and Osteolysis by Modulating the Tumor-Bone Microenvironment
Current Molecular Medicine